Thesis icon

Thesis

Risk factors for haemorrhage in patients with haematological malignancies

Abstract:

Haematological malignancies and their treatment lead to prolonged periods of severe thrombocytopenia (platelet count ≤ 50 x 109/l). Despite the use of prophylactic platelet transfusions, haemorrhage remains an important complication during this thrombocytopenic period. Within a 30 day period up to 70% of patients have clinically significant haemorrhage (World Health Organization (WHO) grade 2 or above bleeding) and up to 10% have severe or life-threatening haemorrhage (WHO grade...

Expand abstract

Actions


Authors


Contributors

Role:
Supervisor
Role:
Supervisor
Institution:
University of Oxford
Research group:
Oxford Clinical Research in Transfusion Medicine
Oxford college:
St Cross College
Department:
Medical Sciences Division - Clinical Laboratory Sciences
More from this funder
Funding agency for:
Lise Jane Estcourt
Publication date:
2014
Type of award:
DPhil
Level of award:
Doctoral
URN:
uuid:4efbd9b1-62e5-4536-a5ee-df5eea4620d0
Local pid:
ora:9012

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP